CA1098444A - Preparations de peptide a action prolongee - Google Patents

Preparations de peptide a action prolongee

Info

Publication number
CA1098444A
CA1098444A CA253,137A CA253137A CA1098444A CA 1098444 A CA1098444 A CA 1098444A CA 253137 A CA253137 A CA 253137A CA 1098444 A CA1098444 A CA 1098444A
Authority
CA
Canada
Prior art keywords
calcitonin
base
salt
preparations
particle size
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA253,137A
Other languages
English (en)
Inventor
Leo Geller
Rene Maier
Werner Rittel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy Investments Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Investments Ltd filed Critical Ciba Geigy Investments Ltd
Application granted granted Critical
Publication of CA1098444A publication Critical patent/CA1098444A/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
CA253,137A 1975-05-26 1976-05-21 Preparations de peptide a action prolongee Expired CA1098444A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH6719/75 1975-05-26
CH671975 1975-05-26

Publications (1)

Publication Number Publication Date
CA1098444A true CA1098444A (fr) 1981-03-31

Family

ID=4313966

Family Applications (1)

Application Number Title Priority Date Filing Date
CA253,137A Expired CA1098444A (fr) 1975-05-26 1976-05-21 Preparations de peptide a action prolongee

Country Status (14)

Country Link
JP (1) JPS51144721A (fr)
AU (1) AU507537B2 (fr)
BE (1) BE842189A (fr)
CA (1) CA1098444A (fr)
DE (1) DE2623074A1 (fr)
FR (1) FR2312260A1 (fr)
GB (1) GB1548984A (fr)
HK (1) HK15982A (fr)
IE (1) IE43770B1 (fr)
IL (1) IL49653A (fr)
MY (1) MY8200284A (fr)
NL (1) NL7605559A (fr)
NZ (1) NZ180945A (fr)
ZA (1) ZA763096B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL70489A0 (en) * 1982-12-29 1984-03-30 Armour Pharma Pharmaceutical compositions containing calcitonin
JPS61267528A (ja) * 1984-11-26 1986-11-27 Yamanouchi Pharmaceut Co Ltd 吸収促進剤を含有するカルシトニン経鼻剤
HU198626B (en) * 1986-05-27 1989-11-28 Sandoz Ag Process for producing pharmaceutical compositions comprising somatostatin analogues as active ingredient
HU205861B (en) * 1986-12-19 1992-07-28 Sandoz Ag Process for producing hydrosole of pharmaceutically effective material
MY102411A (en) * 1986-12-23 1992-06-17 Ciba Geigy Ag Nasal solutions
GB9120672D0 (en) * 1991-09-28 1991-11-06 Ciba Geigy Ag Pharmaceutical compositions
IT1255895B (it) * 1992-10-20 1995-11-17 Laura Chiodini Composizioni farmaceutiche contenenti una calcitonina
DE69917000T2 (de) * 1998-02-25 2005-04-21 Abbott Lab Butorphanol enthaltende formulierungen mit verzögerter freisetzung
WO2023089240A1 (fr) * 2021-11-19 2023-05-25 Nanoform Finland Oyj Composition comprenant un principe actif de taille nanométrique

Also Published As

Publication number Publication date
AU1425276A (en) 1977-12-01
HK15982A (en) 1982-04-08
FR2312260A1 (fr) 1976-12-24
FR2312260B1 (fr) 1978-12-08
JPS51144721A (en) 1976-12-13
IL49653A0 (en) 1976-07-30
MY8200284A (en) 1982-12-31
ZA763096B (en) 1978-01-25
GB1548984A (en) 1979-07-18
BE842189A (fr) 1976-11-25
NZ180945A (en) 1978-07-10
IE43770B1 (en) 1981-05-20
AU507537B2 (en) 1980-02-21
IE43770L (en) 1976-11-26
IL49653A (en) 1979-07-25
NL7605559A (nl) 1976-11-30
DE2623074A1 (de) 1976-12-09

Similar Documents

Publication Publication Date Title
EP0618807B1 (fr) Formulation pharmaceutique stabilisee comportant une somatotrophine et de l'histidine
US4675189A (en) Microencapsulation of water soluble active polypeptides
AU627174B2 (en) Human growth hormone formulation
US3869549A (en) Injectable oily peptide preparations and processes for their manufacture
US5849700A (en) Pharmaceutical formulation
CA1098444A (fr) Preparations de peptide a action prolongee
KR20030033002A (ko) 그렐린 길항제
CN1165034A (zh) 含有人生长激素的药物制剂
KR850000414B1 (ko) 아실펩타이드의 제조방법
WO1992014449A1 (fr) Systeme d'administration microparticulaire a liberation regulee pour des proteines
US5002771A (en) Calcitonin suppository formulations
WO1999047160A1 (fr) Solutions peptidiques aqueuses stabilisees
AU738413B2 (en) Human growth hormone-containing aqueous pharmaceutical composition
CA1335924C (fr) Cristaux mixtes d'insuline et de derives d'insuline, methode de preparation, produits pharmaceutiques en contenant et utilisation dans le traitement du diabete sucre
DE585300T1 (de) Galaninantagonist.
AU2008235215A2 (en) Pharmaceutical formulations of GHRH molecules
JPH11515002A (ja) 副甲状腺ホルモンを含む安定な医薬投与形態
AU2003304382A1 (en) Sincalide formulations
NZ215730A (en) Sustained-release peptide compositions containing proteins as carriers
US7030091B2 (en) Non-aqueous injectable formulation preparation with pH adjusted for extended release of somatotropin
US3803309A (en) Growth hormone release stimulating pharmaceutical preparations of n-acetyl-10-17 aminoacid acth-sequence peptides
US7048938B2 (en) Non-aqueous injectable formulations for extended release of somatotropin
JPH0372046B2 (fr)
Botella et al. In vivo inhibitory effect of lanreotide (BIM 23014), a new somatostatin analog, on prostaglandin-and cholera toxin-stimulated intestinal fluid in the rat
WO1991013601A1 (fr) Presentation de medicaments sous forme de suppositoires a la calcitonine

Legal Events

Date Code Title Description
MKEX Expiry